Structured intermittent treatment for HIV disease: Necessary concession or premature compromise?

被引：15

作者：

Havlir, DV ^{[1
]}

机构：

[1] Univ Calif San Diego, Div Infect Dis, San Diego, CA 92103 USA

来源：

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | 2002年 / 99卷 / 01期

关键词：

D O I：

10.1073/pnas.022629399

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

页码：4 / 6

页数：3

共 31 条

[1] APETREI C, 2001, 5 INT WORKSH HIV DRU, V6, P77
[2] Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination
Barouch, DH
Santra, S
Schmitz, JE
Kuroda, MJ
Fu, TM
Wagner, W
Bilska, M
Craiu, A
Zheng, XX
Krivulka, GR
Beaudry, K
Lifton, MA
Nickerson, CE
Trigona, WL
Punt, K
Freed, DC
Guan, LM
Dubey, S
Casimiro, D
Simon, A
Davies, ME
Chastain, M
Strom, TB
Gelman, RS
Montefiori, DC
Lewis, MG
Emini, EA
Shiver, JW
Letvin, NL
[J]. SCIENCE, 2000, 290 (5491) : 486 - 492
[3] Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
Chun, TW
Stuyver, L
Mizell, SB
Ehler, LA
Mican, JAM
Baseler, M
Lloyd, AL
Nowak, MA
Fauci, AS
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (24) : 13193 - 13197
[4] HIV POPULATION-DYNAMICS IN-VIVO - IMPLICATIONS FOR GENETIC-VARIATION, PATHOGENESIS, AND THERAPY
COFFIN, JM
[J]. SCIENCE, 1995, 267 (5197) : 483 - 489
[5] Retroviral rebound syndrome after cessation of suppressive antiretroviral therapy in three patients with chronic HIV infection
Colven, R
Harrington, RD
Spach, DH
Cohen, CJ
Hooton, TM
[J]. ANNALS OF INTERNAL MEDICINE, 2000, 133 (06) : 430 - 434
[6] HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression
Davey, RT
Bhat, N
Yoder, C
Chun, TW
Metcalf, JA
Dewar, R
Natarajan, V
Lempicki, RA
Adelsberger, JW
Millers, KD
Kovacs, JA
Polis, MA
Walker, RE
Falloon, L
Masur, H
Gee, D
Baseler, M
Dimitrov, DS
Fauci, AS
Lane, HC
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (26) : 15109 - 15114
[7] Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: Effects on virologic, immunologic, and toxicity parameters
Dybul, M
Chun, TW
Yoder, C
Hidalgo, B
Belson, M
Hertogs, K
Larder, B
Dewar, RL
Fox, CH
Hallahan, CW
Justement, JS
Migueles, SA
Metcalf, JA
Davey, RT
Daucher, M
Pandya, P
Baseler, M
Ward, DJ
Fauci, AS
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (26) : 15161 - 15166
[8] Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study
Fellay, J
Boubaker, K
Ledergerber, B
Bernasconi, E
Furrer, H
Battegay, M
Hirschel, B
Vernazza, P
Francioli, P
Greub, G
Flepp, M
Telenti, A
[J]. LANCET, 2001, 358 (9290) : 1322 - 1327
[9] Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
Finzi, D
Hermankova, M
Pierson, T
Carruth, LM
Buck, C
Chaisson, RE
Quinn, TC
Chadwick, K
Margolick, J
Brookmeyer, R
Gallant, J
Markowitz, M
Ho, DD
Richman, DD
Siliciano, RF
[J]. SCIENCE, 1997, 278 (5341) : 1295 - 1300
[10] The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection
García, F
Plana, M
Ortiz, GM
Bonhoeffer, S
Soriano, A
Vidal, C
Cruceta, A
Arnedo, M
Gil, C
Pantaleo, G
Pumarola, T
Gallart, T
Nixon, DF
Miró, JM
Gatell, JM
[J]. AIDS, 2001, 15 (09) : F29 - F40

← 1 2 3 4 →